Back

prof. dr. R.E.G. Schutgens

prof. dr. R.E.G. Schutgens

Full Professor
prof. dr. R.E.G. Schutgens
  • Hematology/Van Creveldclinic

Biography

Biography

Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Side Activities

Advisory Board Member Horizonscan geneesmiddelen ZonMW

Scientific Editor HemaSphere (the EHA journal)

Co-chair international guideline committee "EHA-ISTH guideline for anricoagulation treatment in patients with inherited bleeding disorders"

Member national guideline committee "Bleeding disorders" (section congenital platelet disorders)

Member national guideline committee "Blood transfusion" (section platelet transfusions)

Research Output (238)

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

Versloot Olav, Iserman Emma, Chelle Pierre, Germini Federico, Edginton Andrea N, Schutgens Roger E G, Iorio Alfonso, Fischer Kathelijn Apr 2022, In: HemaSphere. 6

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT:To WiN study

Heijdra Jessica M., Al Arashi Wala, De Jager Nico C.B., Cloesmeijer Michael E., Bukkems Laura H., Zwaan Christian M., Leebeek Frank W.G., Mathôt Ron A.A., Cnossen Marjon H., Cnossen M. H., Leebeek F. W.G., Zwaan Christian M., Van Vliet I., Fijnvandraat K., Mathot R. A.A., Meijer K., Kruip M. J.H.A., S Polinder Polinder, Coppens M., Tamminga R. Y.J., Meijer K., Laros-Van B. A.P., Brons P., Schols S. E.M., Van Der Meer F. J.M., Eikenboom H. C.J., Schutgens R. E.G., Fischer K., Heubel-Moenen F., Nieuwenhuizen L., Ypma P., Driessens M. H.E., Pw Collins Collins, Liesner R., Chowdary P., Keeling D. 15 Feb 2022, In: BMJ Open. 12 , p. 1-6

Treatment of patients with rare bleeding disorders in the Netherlands:Real-life data from the RBiN study

Maas Dominique P M S M, Saes Joline L, Blijlevens Nicole M A, Cnossen Marjon H, den Exter Paul L, Kruis Ilmar C, Meijer Karina, Nieuwenhuizen Laurens, Peters Marjolein, Schutgens Roger E G, van Heerde Waander L, Schols Saskia E M, 17 Jan 2022, In: Journal of thrombosis and haemostasis : JTH. 20 , p. 833-844 12 p.

Relapse of immune thrombocytopenia after COVID-19 vaccination

van Dijk Wobke Else Maria, Schutgens Roger E G Jan 2022, In: European Journal of Haematology. 108 , p. 84-85 2 p.

Patient-reported outcomes in autosomal inherited bleeding disorders:A systematic literature review

van Hoorn Evelien S., Houwing Maite E., Al Arashi Wala, Leebeek Frank W.G., Hazelzet Jan A., Gouw Samantha C., Schutgens Roger E.G., Schols Saskia E.M., Lingsma Hester F., Cnossen Marjon H., 2022, In: Haemophilia. 28 , p. 197-214 18 p.

Checklist Individual Strength to measure severe fatigue in immune thrombocytopenia

van Dijk Wobke E.M., Penson Adriaan, Kuijlaars Isolde A.R., Suijker Monique, van Galen Karin P.M., Knoop Hans, Schutgens Roger E.G. 2022, In: British Journal of Haematology. 197 , p. e41-e44

Reduced cardiovascular morbidity in patients with hemophilia:results of a 5-year multinational prospective study

Van Der Valk Paul, Makris Michael, Fischer Kathelijn, Tait Robert C, Chowdary Pratima, Collins Peter W, Meijer Karina, van Vulpen Lize F D, Mauser-Bunschoten Eveline, Schutgens Roger E G 8 Dec 2021, In: Blood Advances. 6 , p. 902-908 7 p.

Mycophenolate Mofetil for Immune Thrombocytopenia

van Dijk Wobke E M, Schutgens Roger E G 2 Dec 2021, In: The New England journal of medicine. 385

Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF):a randomised, open-label, phase 2 trial

Schreuder Floris H B M, van Nieuwenhuizen Koen M, Hofmeijer Jeannette, Vermeer Sarah E, Kerkhoff Henk, Zock Elles, Luijckx Gert-Jan, Messchendorp Gert P, van Tuijl Julia, Bienfait H Paul, Booij Suzanne J, van den Wijngaard Ido R, Remmers Michel J M, Schreuder Antonia H C M L, Dippel Diederik W, Staals Julie, Brouwers Paul J A M, Wermer Marieke J H, Coutinho Jonathan M, Kwa Vincent I H, van Gelder Isabelle C, Schutgens Roger E G, Zweedijk Berber, Algra Ale, van Dalen Jan Willem, Jaap Kappelle L, Rinkel Gabriel J E, van der Worp H Bart, Klijn Catharina J M, Nov 2021, In: The Lancet. Neurology. 20 , p. 907-916 10 p.

Coordinating physiotherapy care for persons with haemophilia

Timmer Merel A., Blokzijl Johan, Schutgens Roger E. G., Veenhof Cindy, Pisters Martijn F. Nov 2021, In: Haemophilia. 27 , p. 1051-1061 11 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet